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 1 INTRODUCTION 21 
 22 
PCBs were first produced in 1929 and were widely used throughout the 20th century for a 23 
variety of industrial uses such as dielectric fluids, hydraulic fluids and plasticisers. PCBs 24 
are a group of 209 ‘man made’ compounds that were produced as blends, each containing a 25 
specific mixture of different PCB congeners. These blends were sold under trade names 26 
based on their chlorine content. Monsanto was the market leader in worldwide PCB 27 
production and produced approximately 1.2 million tonnes which accounted for more than 28 
half of the global total.1 Monsanto produced nine main Aroclors, accounting for 99.97% of 29 
production,2 each identified with a four digit code. For example, Aroclor 1260 contained 30 
an end product with 60% chlorine by weight. Similar naming systems and production 31 
methods were used by the other manufacturers, resulting in the proportions of congeners in 32 
Aroclor 1260, Clophen A60 and Kanechlor 600 being almost identical.3 PCB production in 33 
the US peaked in 1970.2 However, production rates decreased steadily throughout the 70’s 34 
as the health and environmental risks from PCBs began to be better understood. In the 35 
United States this resulted in passing of the Toxic Substances Control Act in 1976 and the 36 
phasing out of PCBs which began in 1979.4 PCBs have been phased out in open systems 37 
but they can still be found in closed systems, e.g. as dielectric fluids in electrical 38 
equipment. They are highly persistent and are still routinely found in environmental and 39 
human samples across the globe. 40 
 41 
All humans have been exposed to background concentrations of PCBs; however there are 42 
also unfortunate events where individuals are exposed to elevated concentrations of PCBs. 43 
In litigation cases it is especially important to differentiate these specific exposure events 44 
from background exposure, as well as identifying the source of contamination and age 45 
dating the exposure period. Age dating PCB exposure is a complex task but assessments 46 
can be made because different PCB congeners have different residence times in the human 47 
body. 48 
 49 
 50 
 51 
 2 FACTORS AFFECTING THE PCB SIGNATURE IN HUMANS 52 
 53 
PCBs do not occur naturally in the environment but are present due to releases from human 54 
activity. A variety of post release processes, e.g. volatilization, dispersion and 55 
biodegradation, can all alter the PCB signature in the environment.3 However, further 56 
important changes to the PCB signature can also occur during and after an exposure event. 57 
These changes can occur during intake (how PCBs enter the body), uptake (how and where 58 
PCBs are absorbed once they enter the body), and post-uptake (factors such as 59 
biotransformation and elimination). 60 
 61 
2.1  Intake of PCBs 62 
PCBs enter humans through three main pathways: ingestion, inhalation and dermal contact. 63 
The vast majority of people will only be exposed to background concentrations of PCBs, 64 
which will predominantly occur through the ingestion of contaminated foods.5 For the UK 65 
population it was calculated that food consumption was responsible for 97% of the total 66 
exposure to PCBs.6 As well as affecting the total intake of PCBs, a person’s diet will also 67 
influence their specific congener profile because the PCB signature is different for 68 
different food groups.7 The PCB signature in plants tends to be more closely related to the 69 
atmospheric signature than the signature of the soil they were grown in.8 This means that 70 
vegetables and cereals contain higher proportions of the more volatile, less chlorinated 71 
congeners such as CB-28. Lipid rich food groups such as fish and red meat tend to contain 72 
higher proportions of the more chlorinated congeners along with higher total PCB 73 
concentrations.6 As a result, the major source of PCBs in western countries tends to be 74 
from fish and meat, whereas cereals are an important source of PCBs in countries such as 75 
India where less meat is consumed.9 Dermal intake and inhalation are normally considered 76 
to be only minor pathways for PCB exposure. However, PCBs do have a relatively high 77 
dermal absorption factor (0.14)10 and there have been some instances where inhalation has 78 
proved to be an important pathway.11,12 In instances where exposure was through dermal 79 
and inhalation pathways, individuals have contained high proportions of the less 80 
chlorinated congeners.11,13  81 
 82 
2.2  Uptake of PCBs 83 
Once PCBs have entered the body the rate of uptake is relatively high, a study undertaken 84 
in 1972 showed that 88% of the sum of various PCB congeners was absorbed in 85 
preadolescent girls.14 PCBs are highly lipophilic, with log Kow values ranging from 4.3 (for 86 
PCB 2) up to 8.26 (for PCB 209),15 which helps to explain why they accumulate in the 87 
body. As PCBs are hydrophobic, individuals with higher body lipid contents tend to have 88 
higher concentrations of PCBs. Therefore, when comparing PCB concentrations between 89 
individuals, results are often lipid normalised and recorded in ng g-1 lipid. Due to obvious 90 
ethical reasons PCB fractionation in different human organs has not been widely studied. 91 
However, fractionation has been observed in humans for polybrominated diphenyl ethers, 92 
with enrichment of the less brominated congeners in the umbilical cord blood16 and breast 93 
milk.17 The majority of fractionation studies have been undertaken on animals where 94 
fractionation driven by the log Kow values has resulted in accumulation of less chlorinated 95 
PCBs (along with dioxins and furans) in the eggs of fish18 and birds.19 Fractionation may 96 
not occur across all tissue types however; e.g. no significant difference was observed in the 97 
PCB signature in liver and muscle tissue from 7 different predatory bird species in 98 
Belgium.20 99 
 100 
2.3  Post uptake factors  101 
Once PCBs are taken up by humans they do not remain in the body at constant levels. 102 
Individual PCB concentrations and the overall PCB signature are altered by 103 
biotransformation and elimination. PCBs are fairly insoluble and therefore need to be 104 
transformed into more soluble compounds before they can be excreted.21 This usually 105 
involves the introduction of an epoxide, hydroxylation or conjugation to produce more 106 
water soluble derivatives.22 The metabolic breakdown pathway is usually initiated through 107 
hydroxylation involving the cytochrome P450 isozymes (CYP1A and CYP2B). These are 108 
not only triggered by the presence of PCBs but can also be activated by PAHs from eating 109 
barbecued food, smoking, drinking coffee or by consuming cruciferous vegetables such as 110 
broccoli.23,24 Not all PCBs are biotransformed in the same way or at the same rate. The 111 
structure of the PCB determines which enzyme preferentially transforms it. Co-planar 112 
PCBs with no or one ortho chlorines are preferred substrates for CYP1A, whereas CYP2B 113 
will transform most PCBs.22 In general the more chlorinated congeners are more resistant 114 
to biotransformation than the less chlorinated congeners but the exact position of chlorine 115 
atoms on the biphenyl is also very important.25,26 Based on their resistance in humans, 116 
PCBs can be classified into two groups; steady state PCBs and episodic PCBs. Hansen27 117 
classified steady state PCBs as ‘more persistent CBs that are commonly reported’, whereas 118 
episodic PCBs were classified as PCBs that are ‘generally present only transiently and may 119 
be detectable in a small fraction of a survey population’.  120 
 121 
 122 
 3 IDENTIFICATION OF EPISOIC AND STEADY STATE CONGENERS 123 
 124 
As stated in section 2, there are many factors that can affect the PCB signature in humans. 125 
One of the most important factors is the resistance of a PCB to biotransformation and 126 
elimination.26 The difference in resistance of certain PCBs can result a noticeable shift in 127 
the PCB signature over time. Recently exposed individuals contain higher proportions of 128 
episodic congeners and historically exposed individuals contain higher proportions of 129 
steady state congeners. Therefore, when age dating human exposure, it is important to 130 
correctly identify which congeners are steady state and which are episodic. The following 131 
section outlines how Megson et al.26 used the National Health and Nutrition Examination 132 
Survey (NHANES) to identify steady state and episodic PCBs.  133 
 134 
3.1  Interrogation of the NHANES dataset 135 
NHANES is a continuous survey that was designed to monitor the health of the US 136 
population through interviews, physical examination and laboratory analysis. This includes 137 
the routine determination of a range of contaminants, including a total of 37 PCBs in 138 
serum. The most recent survey to include PCB analysis was undertaken in 2003-04 using 139 
serum obtained from approximately 2000 individuals. Samples were analysed using high 140 
resolution gas chromatography / high resolution mass spectrometry (HRGC/HRMS) and 141 
quantified by isotope dilution. Data from the NHANES surveys are publically available 142 
from the Centers for Disease Control and Prevention (CDC)28,29 along with information 143 
regarding the collection and analysis of the serum samples and data quality procedures.30 144 
 145 
Once downloaded, the NHANES dataset was interrogated by splitting participants into 74 146 
yearly age groups from 12 – 85 years old based on their age at the time of participation in 147 
the survey. A box and whisker plot of PCB concentrations in each age group was plotted 148 
for each congener to identify any difference in PCB concentration with age. Scatter plots 149 
of participant age versus log10 transformed PCB concentration were also produced for each 150 
congener. A linear regression was applied to each scatter plot and the significance of the 151 
resultant relationship between PCB concentration and age was calculated as a P-value. The 152 
results were used to identify two groups of PCBs; steady state congeners which showed a 153 
significant increase in concentration with age and episodic congeners which showed no 154 
significant increase in concentration with age (Figure 1). 155 
 156 
 157 
 158 
Figure 1 Steady state and episodic congeners identified from regression analysis 159 
(Figure adapted from Science of the Total Environment, 461–462, Megson, D., 160 
O’Sullivan, G., Comber, S., Worsfold, P. J., Lohan, M. C., Edwards, M. R., 161 
Shields, W. J., Sandau, C. D. & Patterson Jr, D. G., Elucidating the structural 162 
properties that influence the persistence of PCBs in humans using the National 163 
Health and Nutrition Examination Survey (NHANES) dataset. Copyright 164 
(2013), with permission from Elsevier)  165 
 166 
Principal component analysis (PCA) was undertaken to further evaluate if there was any 167 
relationship between age and PCB signature. Prior to undertaking PCA, PCB 168 
concentrations were standardised by dividing the concentration of each PCB by the sum of 169 
the concentrations of the 37 PCBs reported in the sample. The data were then normalised 170 
in two steps, initially taking the square root of the proportion and then subtracting the mean 171 
and dividing by the standard deviation. These transformations were undertaken to prevent 172 
high concentration variables from dominating the analysis.31 The scores plot showed a 173 
clear gradient in the age of participant along the first principal component axis (Figure 2). 174 
 175 
 176 
Figure 2 Scores plot showing gradient in participant age along PC1 (Reprinted from 177 
Science of the Total Environment, 461–462, Megson, D., O’Sullivan, G., 178 
Comber, S., Worsfold, P. J., Lohan, M. C., Edwards, M. R., Shields, W. J., 179 
Sandau, C. D. & Patterson Jr, D. G., Elucidating the structural properties that 180 
influence the persistence of PCBs in humans using the National Health and 181 
Nutrition Examination Survey (NHANES) dataset. Copyright (2013), with 182 
permission from Elsevier) 183 
 184 
The loadings plot was used to identify three groups of congeners (Figure 3). Group 1 (with 185 
positive PC1 values) contained PCBs with predominantly 25- and 236- substitution which 186 
were present in higher proportions in the younger participants. Group 2 (with negative PC1 187 
values) contained PCBs with predominantly 2345- and 23456- substitution which were 188 
present in higher proportions in the older participants. A third group was also separated 189 
(with negative PC2 values) containing PCBs with predominantly 245- substitution. The 190 
PCBs in Group 2 are indicative of steady state congeners that have accumulated in higher 191 
proportions over time as they are more resistant to biotransformation and elimination. The 192 
PCBs in Group 1 are indicative of episodic PCBs as the younger individuals have not been 193 
alive as long at the older participants and therefore the fractionation of episodic and steady 194 
state congeners is less pronounced. Group 3 was poorly correlated with age but contained 195 
PCBs that have previously been recorded in depleted proportions due to 196 
biotransformation.32 197 
 198 
 199 
Figure 3 Loadings plot showing groups of PCBs based on chlorine position (Figure 200 
adapted from Science of the Total Environment, 461–462, Megson, D., 201 
O’Sullivan, G., Comber, S., Worsfold, P. J., Lohan, M. C., Edwards, M. R., 202 
Shields, W. J., Sandau, C. D. & Patterson Jr, D. G., Elucidating the structural 203 
properties that influence the persistence of PCBs in humans using the National 204 
Health and Nutrition Examination Survey (NHANES) dataset. Copyright 205 
(2013), with permission from Elsevier) 206 
 207 
3.2  Structure of episodic and steady state congeners 208 
The results of the regression analysis and PCA were considered along with the cluster 209 
analysis presented in Megson et al.26. These results were compared with previous studies 210 
on PCB metabolism25,27,33 to establish how the structure of PCBs affects their resistance to 211 
biotransformation and elimination in humans. The results showed that PCBs with chlorine 212 
substitution in the 25- and 236- positions appeared to be particularly susceptible to 213 
biotransformation and elimination whereas PCBs with 234-, 245-, 345- and 2345- 214 
substitution appeared to be more resistant. PCBs with no para chlorine and adjacent meta 215 
chlorine appeared to be the most susceptible (Figure 4). This is believed to be because 216 
these are more easily hydrolysed, which is the first metabolic step in the cytochrome P450 217 
breakdown pathway.13 218 
 219 
 220 
 221 
Figure 4 Structure of some episodic and steady state PCBs 222 
 223 
 224 
 4 PCB ANALYSIS BY GCxGC-TOFMS 225 
 226 
PCBs were first discovered in environmental samples in 1966.34 However, due to their 227 
structural similarity, the separation of all 209 PCBs still presents a significant analytical 228 
challenge. When age dating exposure it is essential to be able to resolve episodic and 229 
steady state PCBs. The first fully comprehensive PCB analysis was undertaken by Frame 230 
in 1997; retention times for all 209 PCBs where documented using multiple analysis on 231 
several different GC columns.35 However, to this day, all 209 PCBs have not been 232 
separated in one analytical run. Several authors have reported the separation of over 190 233 
PCBs using GCxGC-TOFMS.36-39 The following section outlines the separation of 200 234 
congeners by Megson et al.39 and gives examples of how the method can be applied to the 235 
determination of PCBs in biological samples, thus demonstrating its potential for age 236 
dating human exposure to PCBs. 237 
 238 
4.1   Identification of episodic and steady state PCBs 239 
 240 
Nine PCB congener standard calibration mixtures (CS1 to CS9; AccuStandard) containing 241 
10 µg mL-1 of each PCB in 1 mL of isooctane were combined to produce a solution 242 
containing all 209 congeners. This was analysed using a time-of-flight mass spectrometer, 243 
(LECO, St. Joseph, MI Pegasus 4D) coupled to a two dimensional gas chromatograph 244 
(Agilent Technologies 7890A) equipped with a thermal modulator (LECO, St. Joseph, 245 
MI). The gas chromatograph was installed with a Rtx-PCB (60 m x 0.18 mm x 0.18 µm) 246 
1D column and a Rxi-17 (1.5 m x 0.1 mm x 0.1 µm) 2D column (further settings are 247 
reported in 39). Two hundred of the 209 congeners were separated, with the remaining 9 248 
co-eluting congeners comprising; three doublets (CB65 + CB62, CB160 + CB163 and 249 
CB201 + CB204) and one triplet (CB20 + CB21 + CB33). Of these 9 congeners only 4 250 
(CB20, CB33, CB163, CB201) were present in detectable concentrations in the 5 most 251 
common commercial Aroclor mixtures, and only 1 (CB21) has a chlorine substitution 252 
pattern indicative of a steady state or episodic congener. This method therefore provides 253 
excellent separation of episodic and steady state congeners. A 2D contour plot produced 254 
from the chromatogram of the 209 PCB mixture is shown in Figure 5. 255 
 256 
 257 
 258 
Figure 5 Contour plot produced from a mixture containing all 209 PCBs using 259 
GCxGC-TOFMS  260 
 261 
 262 
4.2  Separation of PCBs in biological samples 263 
 264 
The application of the method to biological matrices was demonstrated through analysis of 265 
several marine animal tissues including; a whiting (Merlangius merlangus) liver, a 266 
guillemot (Uria aalge) liver and a liver, stomach, gut and heart obtained from the same 267 
Leach’s storm petrel (Oceanodroma leucorhoa). The largest number of PCBs identified in 268 
these samples was 137 in the whiting liver, with a further 18 tentatively identified with a 269 
signal-to-noise ratio <10. The method also identified 120 PCBs in the guillemot liver with 270 
a further 11 tentatively identified with a signal-to-noise ratio <10. In the petrel samples 77 271 
PCBs were identified in the heart, 83 in the stomach, 95 in the liver and 100 in the gut. 272 
Results from all samples were compared using Euclidian distance analysis to determine if 273 
the PCB signature was similar for the different petrel organs and/or if the signature in the 274 
liver was similar across the three species. Prior to statistical analysis all PCBs detected in 275 
less than 4 of the 6 samples were removed from the data set. This was undertaken to reduce 276 
the effect of using a LOD substitution value for instances where around 30% of the data 277 
was below the detection limit.40 The remaining 93 PCBs with values < LOD were reported 278 
at 0.5 LOD. All PCB results were standardised by converting each PCB to proportions of 279 
the total PCB count in that sample. The data were normalised by taking the square root of 280 
the proportion then subtracting the mean and dividing by the standard deviation. Euclidian 281 
distance was calculated for the samples and the results presented as a cluster diagram 282 
(Figure 6).  The cluster diagram shows the high similarity in the PCB signature between 283 
the samples obtained from the petrel, indicating that the signature was well retained 284 
throughout the animal’s organs. However, there were distinct differences in the signature 285 
from the stomach sample which showed elevated proportions of PCB 138 and PCB 180. 286 
This may be associated with the PCB signature in undigested food within the stomach. 287 
 288 
 289 
 290 
Figure 6 Cluster plot of Euclidian distance of the PCB signature in four petrel 291 
organs, guillemot liver and whiting liver  292 
 293 
 294 
 295 
 5 CONCLUSIONS 296 
 297 
Age dating PCB exposure is a complex task; however assessments can be made because 298 
different PCB congeners have different residence times in the human body. Episodic PCBs 299 
with chlorine substitution in the 25- and 236- positions appeared to be particularly 300 
susceptible to biotransformation and elimination whereas steady state PCBs with 234-, 301 
245-, 345- and 2345- substitution appeared to be more resistant. When age dating exposure 302 
it is essential to be able to resolve these episodic and steady state PCBs. Analysis using 303 
single column chromatography will often result in the co-elution of several key congeners. 304 
However, analysis by comprehensive two-dimensional gas chromatography was able to 305 
resolve 200 of the 209 congeners, a significant improvement on one dimensional gas 306 
chromatography. The method was tested on biological matrices by conducting a 307 
fingerprinting exercise which distinguished different Lech’s storm petrel organs from 308 
whiting and guillemot samples. The results showed that although different organs from the 309 
same petrel contained different total PCB concentrations the signature was well retained 310 
throughout each of the analysed organs. However, there were still subtle differences 311 
between the PCB signature of the different storm petrel organs.  312 
 313 
Research is currently on-going to apply the statistical and analytical methods discussed in 314 
this paper to age date human exposure to PCBs. 315 
 316 
 317 
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